Clinical Trial Update: Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial assessed whether glycopyrrolate reduces nausea and vomiting following ERCP; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea and Vomiting

Drugs mentioned

• Glycopyrrolate (glycopyrrolate)

Snippet

Sponsor: Jie Chen | Conditions: Nausea and Vomiting | Phase 1, Phase 2 | Status: COMPLETED